Trial Profile
A Study Evaluating Outcomes Of Ledipasvir-Sofosbuvir (Harvoni) For Hepatitis C Virus Infection In Non-Transplant Patients At A Diverse, Urban, Tertiary Center Clinical Setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 May 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 26 May 2017 New trial record
- 09 May 2017 Results presented at the Digestive Disease Week 2017.